BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21738818)

  • 1. The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer.
    Barqawi AB; Turcanu R; Gamito EJ; Lucia SM; O'Donnell CI; Crawford ED; La Rosa DD; La Rosa FG
    Int J Clin Exp Pathol; 2011 Jun; 4(5):468-75. PubMed ID: 21738818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy.
    Brimo F; Schultz L; Epstein JI
    J Urol; 2010 Jul; 184(1):126-30. PubMed ID: 20478583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution.
    Chen SD; Fava JL; Amin A
    Virchows Arch; 2016 Feb; 468(2):213-8. PubMed ID: 26563400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy.
    Epstein JI; Walsh PC; Sanfilippo F
    Am J Surg Pathol; 1996 Jul; 20(7):851-7. PubMed ID: 8669533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy.
    Yaxley W; Delahunt B; Yaxley J; Thunders MC; Kenwright DN; Egevad L; Samaratunga H
    Pathology; 2022 Oct; 54(6):694-699. PubMed ID: 35613972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.
    Fanning DM; Kay E; Fan Y; Fitzpatrick JM; Watson RW
    BJU Int; 2010 Mar; 105(5):631-5. PubMed ID: 19732053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens.
    Evans AJ; Henry PC; Van der Kwast TH; Tkachuk DC; Watson K; Lockwood GA; Fleshner NE; Cheung C; Belanger EC; Amin MB; Boccon-Gibod L; Bostwick DG; Egevad L; Epstein JI; Grignon DJ; Jones EC; Montironi R; Moussa M; Sweet JM; Trpkov K; Wheeler TM; Srigley JR
    Am J Surg Pathol; 2008 Oct; 32(10):1503-12. PubMed ID: 18708939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens.
    Djavan B; Kadesky K; Klopukh B; Marberger M; Roehrborn CG
    Eur Urol; 1998; 33(3):261-70. PubMed ID: 9555550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score.
    Fine SW; Epstein JI
    J Urol; 2008 Apr; 179(4):1335-8; discussion 1338-9. PubMed ID: 18289601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease.
    Cury J; Coelho RF; Srougi M
    Sao Paulo Med J; 2008 Mar; 126(2):119-22. PubMed ID: 18553035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver variability in the pathological assessment of radical prostatectomy specimens: findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.
    Persson J; Wilderäng U; Jiborn T; Wiklund PN; Damber JE; Hugosson J; Steineck G; Haglind E; Bjartell A
    Scand J Urol; 2014 Apr; 48(2):160-7. PubMed ID: 23906418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
    Karram S; Trock BJ; Netto GJ; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer.
    Anderson BB; Oberlin DT; Razmaria AA; Choy B; Zagaja GP; Shalhav AL; Meeks JJ; Yang XJ; Paner GP; Eggener SE
    Eur Urol; 2017 Sep; 72(3):455-460. PubMed ID: 27986368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
    Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
    Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
    Egan AJ; Bostwick DG
    Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gleason score concordance on biopsy-confirmed prostate cancer: is pathological re-evaluation necessary prior to radical prostatectomy?
    Truesdale MD; Cheetham PJ; Turk AT; Sartori S; Hruby GW; Dinneen EP; Benson MC; Badani KK
    BJU Int; 2011 Mar; 107(5):749-754. PubMed ID: 20840549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.